Improved survival in patients with early stage low-grade follicular lymphoma treated with radiation: A surveillance, epidemiology, and end results database analysis

Cancer

Volumn 116, Issue 16, 2010, Pages 3843-3851

  Pugh, Thomas J ^a   Ballonoff, Ari ^a   Newman, Francis ^a   Rabinovitch, Rachel ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Follicular lymphoma; Indolent non Hodgkin lymphoma; Radiation therapy; Watchful waiting

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGE; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CAUSE SPECIFIC SURVIVAL; FEMALE; FOLLICULAR LYMPHOMA; HUMAN; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RACE; SEX; CANCER REGISTRY; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; EVALUATION STUDY; LYMPHOMA, FOLLICULAR; MIDDLE AGED; MORTALITY; TREATMENT OUTCOME;

DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHOMA, FOLLICULAR; MALE; MIDDLE AGED; SEER PROGRAM; TREATMENT OUTCOME;

EID: 77956813753     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25149     Document Type: Article

References (27)

1. National Cancer Institute. Available at: http://www.cancer.gov/ cancertopics/types/non-hodgkin Accessed October 6, 2008.
2. A clinical evaluation of the International Lymphoma Study Group Classification of non-Hodgkin's Lymphoma. The Non-Hodgkin's Lymphoma Classification Project. Blood. 1997;89:3909-3918.
3. Armitage J, Weisenburger D. New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. J Clin Oncol. 1998;16:2780-2795.
4. MacManus MP, Hoppe RT. Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University. J Clin Oncol. 1996;14:1282-1290.
5. Petersen PM, Gospodarowicz R, Tsang R, et al. Long term outcome in stage I and II follicular lymphoma following treatment with involved field radiation therapy alone. J Clin Oncol. 2004;22:6521.
6. Vaughan Hudson B, Vaughan Hudson G, MacLennan KA, Anderson L, Linch DC. Clinical stage 1 non-Hodgkin's lymphoma: long-term follow-up of patients treated by the British National Lymphoma Investigation with radiotherapy alone as initial therapy. Br J Cancer. 1994;69:1088-1093.
7. Soubeyran P, Eghbali H, Bonichon F, et al. Localized follicular lymphomas: prognosis and survival of stages I and II in a retrospective series of 103 patients. Radiother Oncol. 1988;13:91-98.
8. Guadagnolo BA, Sigui L, Neuberg D, et al. Long term outcome and mortality trends in early stage, grade 1-2 follicular lymphoma treated with radiation therapy. Int J Radiat Oncol Biol Phys. 2006;64:928-934.
9. National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology: Non-Hodgkin Lymphoma. Available at: http://www.nccn.org/professionals/ physician-gls/PDF/nhl.pdf Accessed October 12, 2008.
10. Engelhard M, Stuschke M. Report on workshop: UICC workshop "Therapy of NHL in early stages." Part 1: Follicular lymphoma. Ann Hematol. 2001;80:13-15.
11. Kelsey SM, Newland AC, Hudson GV, Jelliffe AM. A British National Lymphoma Investigation randomized trial of single agent chlorambucil plus radiotherapy versus radiotherapy alone in low grade, localized, non-Hodgkins lymphoma. Med Oncol. 1994;11:19-25.
12. Advani R, Rosenberg SA, Horning SJ. Stage I and II follicular non-Hodgkin's lymphoma: long-term follow-up of no initial therapy. J Clin Oncol. 2004;22:1454-1459.
13. Horning SJ, Rosenberg SA. The natural history of initially untreated low grade non-Hodgkin's lymphomas. N Engl J Med. 1984;311:1471-1475.
14. Surveillance, Epidemiology, and End-Results Program. Available at: http://seer.cancer.gov/about Accessed October 12, 2008.
15. Johnson CH, Adamo M. The SEER Program Coding and Staging Manual 2007. National Cancer Institute, NIH Publication number 07-5581. Available at: http://seer.cancer.gov/manuals/2007/SPCSM-2007-maindoc.pdf Accessed October 20, 2008.
16. Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Handbook. 6th ed. New York, NY: Springer; 2002.
17. Solal-Celigny P, Roy P, Colombat P, et al. Follicular lymphoma international prognostic index. Blood. 2004;104:1258-1265.
18. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-458.
19. Mantel N. Evaluation of survival data and 2 new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966;50:163-170.
20. Cox DR. Regression models and life-tables. J R Stat Soc [B]. 1972;34:187-202.
21. Peters MV, Bush RS, Brown TC, et al. The place of radiotherapy in the control of non-Hodgkin's lymphomata. Br J Cancer. 1975;31:386-401.
22. Chen MG, Prosnitz LR, Gonzalez-Serva A, Fischer DB. Results of radiotherapy in control of stage I and II non-Hodgkin's lymphoma. Cancer. 1979;43:1245-1254.
23. Brice P, Bastion Y, Lepage E, et al. Comparison in low-tumor-burden follicular lymphomas between an initial notreatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d'Etude des Lymphomes Folliculaires. Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol. 1997;15:1110-1117.
24. Ardeshna KM, Smith P, Norton A, et al. British National Lymphoma Investigation: long term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced stage non-Hodkin lymphoma - a randomized control trial. Lancet. 2003;362:516-522.
25. Young RC, Longo DL, Glatstein E, et al. The treatment of indolent lymphomas: watchful waiting versus aggressive combined modality treatment. Semin Hematol. 1988;25(supp 2):11-16.
26. Pendlebury S, el Awadi M, Ashley S, et al. Radiotherapy results in early stage low grade nodal non-Hodgkin's lymphoma. Radiother Oncol. 1995;36:167-171.
27. Seymour JF, Pro B, Fuller LM, et al. Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma. J Clin Oncol. 2003;21:2115-2122.